Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 21240019)

1.

Successful treatment of autoimmune hepatitis with methotrexate.

Sultan MI, Biank VF, Telega GW.

J Pediatr Gastroenterol Nutr. 2011 Apr;52(4):492-4. doi: 10.1097/MPG.0b013e3181f3d9c0. No abstract available.

PMID:
21240019
2.

Successful treatment of refractory type 1 autoimmune hepatitis with methotrexate.

Burak KW, Urbanski SJ, Swain MG.

J Hepatol. 1998 Dec;29(6):990-3.

PMID:
9875647
3.

Methotrexate therapy for refractory chronic active autoimmune hepatitis.

Venkataramani A, Jones MB, Sorrell MF.

Am J Gastroenterol. 2001 Dec;96(12):3432-4. No abstract available.

PMID:
11774963
4.

[Methotrexate in the treatment of autoimmune hepatitis].

Ortego Centeno N, Salmerón Escobar J, Callejas Rubio JL, Parra Ruiz J, Benticuaga Martínez MN.

Gastroenterol Hepatol. 2004 May;27(5):344-5. Spanish. No abstract available.

PMID:
15117615
5.

Reversal of cirrhosis in a patient with primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.

Vallone TM, Ditelberg J, Kaplan MM.

Dig Dis Sci. 2005 Jan;50(1):167-70. No abstract available.

PMID:
15712656
6.

Use of immunomodulary agents is difficult in treating autoimmune hepatitis patients.

Gordon FD, Simpson M.

J Clin Gastroenterol. 2004 Oct;38(9):729-30. No abstract available.

PMID:
15365394
7.

Do we need alternative treatment options for autoimmune hepatitis?

Csepregi A, Malfertheiner P.

Curr Gastroenterol Rep. 2006 Jun;8(3):177-8. Review. No abstract available.

PMID:
16764782
8.

Complete regression of cirrhosis after immunosuppressive treatment in autoimmune hepatitis.

Ustundag G, Kuloglu Z, Kirsaçlioğlu CT, Kansu A, Erden E, Girgin N.

Pediatr Int. 2008 Oct;50(5):711-3. doi: 10.1111/j.1442-200X.2008.02714.x. No abstract available.

PMID:
19261129
9.

Deflazacort for type-1 autoimmune hepatitis in a Korean girl.

Bae SH, Kim JS, Kim DH.

J Korean Med Sci. 2006 Aug;21(4):758-60.

10.

Treatment of autoimmune hepatitis: a review of current and evolving therapies.

Jothimani D, Cramp ME, Mitchell JD, Cross TJ.

J Gastroenterol Hepatol. 2011 Apr;26(4):619-27. doi: 10.1111/j.1440-1746.2010.06579.x. Review.

PMID:
21073674
11.

Duration of immunosuppressive therapy in autoimmune hepatitis.

Kanzler S, Gerken G, Löhr H, Galle PR, Meyer zum Büschenfelde KH, Lohse AW.

J Hepatol. 2001 Feb;34(2):354-5. No abstract available.

PMID:
11281572
12.

Autoimmune cholangitis with features of autoimmune hepatitis: successful treatment with immunosuppressive agents and ursodeoxycholic acid.

Li CP, Tong MJ, Hwang SJ, Luo JC, Co RL, Tsay SH, Chang FY, Lee SD.

J Gastroenterol Hepatol. 2000 Jan;15(1):95-8.

PMID:
10719755
13.

Autoimmune liver disease: current therapy.

Zeniya M, Toda G.

Intern Med. 2000 Apr;39(4):346-7. Review. No abstract available.

14.

Autoimmune hepatitis: a fertile field.

Lake JR.

Gut. 2001 Jan;48(1):7-8. No abstract available.

15.

Use of mycophenolate in the treatment of autoimmune hepatitis.

Oo YH, Neuberger J.

Liver Int. 2005 Aug;25(4):687-91. No abstract available.

PMID:
15998416
16.

[Autoimmune hepatitis].

Jüngst C, Lammert F, Strassburg CP.

Dtsch Med Wochenschr. 2013 Dec;138(50):2599-608; quiz 2609-12. doi: 10.1055/s-0033-1349567. Epub 2013 Dec 3. Review. German. No abstract available.

PMID:
24301494
17.

[Autoimmune hepatitis: recent update on diagnosis and treatment].

Lee YS.

Korean J Hepatol. 2006 Sep;12(3):318-32. Review. Korean.

18.

Use of tacrolimus in the treatment of autoimmune hepatitis: a single centre experience.

Tannous MM, Cheng J, Muniyappa K, Farooq I, Bharara A, Kappus M, Luketic V, Stravtiz RT, Fuchs M, Puri P, Sanyal A, Sterling R.

Aliment Pharmacol Ther. 2011 Aug;34(3):405-7. doi: 10.1111/j.1365-2036.2011.04749.x. No abstract available.

PMID:
21726256
19.

Remission with ursodeoxycholic acid of type 1 autoimmune hepatitis resistant to azathioprine and steroids.

Duclos-Vallée JC, Di Martino V, Cazier A, Ballot E, Johanet C, Yamamoto AM, Emile JF, Guettier C, Coutarel P, Cadranel JF.

Gastroenterol Clin Biol. 2005 Nov;29(11):1173-6.

20.

Successful treatment with cyclosporine A of HCV-driven chronic liver disease mimicking autoimmune hepatitis in a patient with common variable immunodeficiency.

Martire B, Gentile A, Francavilla R, De Santis A, De Mattia D.

Immunopharmacol Immunotoxicol. 2005;27(4):535-43.

PMID:
16435575
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk